Rejected at 3:17 p.m. Oct, 31, 2023 ] by Alex
Author: do25.mhshah
Related Note: 1580418788853
Rationale for change

Fluxoetine is an SNRI indicated as first-line therapy for PN

Rejection reason

no source, amboss lists snris as a 1st line option, not ssris

Text Text
Additional Resources Additional Resources
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
Empty field
OME
One by one
Empty field
#AK_Step2_v12::Original_decks::Dorian::fam::nbme #AK_Step2_v12::#Resources_by_rotation::FM::nbme #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::02_Diabetes_Complications::Extra #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::03_Chronic_Diabetes_Complications_SOAP #AK_Step2_v12::#Subjects::Neurology::05_Spinal_Cord::Pain::Neuropathic_Pain #AK_Step2_v12::#Subjects::Neurology::05_Spinal_Cord::Pain::Neuropathic_Pain::Management #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::03_Mood_Stabilizers_&_Antiepileptic_Drugs::05_Gabapentin_&_Pregabalin #AK_Step2_v12::!Shelf::FM::no_dupes::only_step2 #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::01_SSRIs,_SNRIs,_Cyproheptadine #AK_Step2_v12::#SketchyNeurology::10_Neuromuscular_Disorders::04_Neuropathies::01_Neuropathy:_Polyneuropathy #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::20_SNRIs #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::4fm #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3)